• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

vOrtho Douchebaggery

anonymous

Guest
Hows it going in the new division? Bet you're getting lots of new scripts. I wish I could work for Valeant. Do you have a cool colored jacket top notch reps can wear?
 








...................../´¯¯/)
...................,/¯.../
.................../..../
.............../´¯/'..'/´¯¯`·¸
.........../'/.../..../....../¨¯\
..........('(....´...´... ¯~/'..')
...........\..............'...../
............\....\.........._.·´
.............\..............(
..............\..............\